Gujarat Fluorochemicals Ltd

- On December 5, 2025, the International Finance Corporation (IFC) approved an equity investment of Rs. 430 crores in GFCL EV Products Limited, supporting the battery materials business. - Another sovereign fund approved a $82 million equity investment in the battery materials subsidiary in Oman; documentation is in process and expected to be executed shortly. - These investments are in the form of convertible instruments linked to IPO milestones, structured as pure equity with no buyback commitments. - No specific mention of planned new debt fundraising in the call. - The company is focusing on scaling its battery materials business with strategic equity infusion to strengthen the domestic EV supply chain. - Capital expenditure plans, including the Oman battery materials project ($216 million), are funded through these equity investments and internal accruals.

- Rs. 6,000 crores CAPEX planned for battery materials, including the Oman project. - State-of-the-art greenfield advanced battery materials project in Oman with estimated investment of $216 million. - Initial phase of LFP cathode active material plant set up, with future capacity expansion planned. - R-32 refrigerant capacity being built in phases: first phase targeting 20,000 tonnes (slightly delayed to early CY 2026), with potential to expand to 30,000 tonnes by end of CY 2027. - Investments focused on creating integrated battery materials manufacturing, including LiPF6, LFP cathode active material, electrolyte, and fluoropolymer binder capacity. - International Finance Corporation (IFC) approved Rs. 430 crores investment in GFCL EV Products Limited. - Additional $82 million sovereign fund investment in battery materials business pending documentation. - Ongoing capex for debottlenecking and capacity enhancement in fluoropolymers and specialty products to meet higher-value product demand.

- Fluoropolymers business has strong long-term growth plans; fundamentals remain intact despite temporary hiccups such as U.S. tariffs and cautious ordering. - EV battery chemicals segment is shaping up well, with healthy order books and expected full utilization of existing capacity by end of FY 2026. - R-32 refrigerant sales ramp-up expected from Q4 FY 2026; overall refrigerant segment expected to recover from volume and price dips. - Fluoropolymer segment expects volume growth driven by semiconductor sector investment and EV ESS segment momentum. - Battery chemical exports (LiPF6, cathode active materials, fluoropolymer binders) targeted at global markets, with increasing customer acquisition in U.S. and Europe from FY 2027 onward. - Phased capacity addition plans for R-32 refrigerant with plant expansion up to 30,000 tonnes by December 2027. - Fluoropolymer growth expected to return to 15%-20% volume growth as inventory and customer qualification hurdles ease. - Working capital to normalize around 170-180 days to support business growth.

- Fluoropolymers segment expected to continue strong momentum driven by semiconductor sector expansion and EV/ESS adoption, supporting volume and revenue growth in FY 2027 and FY 2028. - Recovery anticipated in refrigerant segment with ramp-up of R-32 sales starting Q4 FY 2026 and expected capacity increase to 20,000 tonnes by mid to end of 2027, improving profitability. - EV battery materials business projected to grow significantly with qualified products like LiPF6 and LFP CAM, aiming for full utilization of current capacity by end of FY 2026 and healthy revenue ramp-up in FY 2027-28. - Challenges like U.S. tariffs, inventory buildup, and delayed antidumping duties impacted near-term growth but expected to normalize and support margin expansion going forward. - Oman project integration within Rs. 6,000 crore CAPEX plan on schedule, supporting future growth. - Overall, long-term growth plans are firmly in place with improved order book visibility and global customer interest, indicating sustained earnings and EPS growth potential.

- The current order book for the battery chemical capacity already built looks very healthy. - The plants commissioned (e.g., for LiPF6 and LFP CAM) are expected to be fully utilized by the end of the current financial year (FY 2026). - For FY 2027 and FY 2028, revenue growth is expected as qualification and commercialization progress for battery materials. - Exact revenue projections for FY 2027 are difficult to provide due to long qualification timelines in critical EV and ESS products. - The Rs. 6,000 crores investment plan for battery materials, including the Oman project, is on track with commissioning expected by mid to end of 2027. - For fluoropolymers and refrigerants, order momentum is improving after tariff reductions and clearing of inventory disruptions. - Overall, healthy order inflows and better visibility support a strong outlook for revenue growth in FY 2027.